Skip to main content

Table 4 Costs of therapy over a 5-year time horizon

From: Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Cost particulars OLAI (€) RLAI (€)
  Mean SD Mean SD
Drug costa 16152.18 71.50 16676.88 82.52
Administration cost 1949.85 13.21 2430.71 21.77
Cost per relapse/hospitalisationb 6860.26 169.61 8955.42 173.35
Other costsc 9047.91 41.76 8886.87 44.14
Total cost per patient 34010.21 207.83 36949.88 251.45
  1. (The Mean and Std Dev are outcomes of the model run over 5 years with 100 replications).
  2. aDrug cost includes cost of study drug and concomitant medications.
  3. bSince the study assumed hospitalisation as proxy for relapse.
  4. cOther costs include specialist visits and other medical costs (i.e. routine management, treatment of adverse events and cost of switching).
  5. SD = Standard deviation.